GLYC
Price
$0.23
Change
-$0.00 (-0.00%)
Updated
Dec 23, 10:39 AM (EDT)
66 days until earnings call
LTRN
Price
$3.05
Change
-$0.09 (-2.87%)
Updated
Dec 23, 11:12 AM (EDT)
73 days until earnings call
Ad is loading...

GLYC vs LTRN

Header iconGLYC vs LTRN Comparison
Open Charts GLYC vs LTRNBanner chart's image
GlycoMimetics
Price$0.23
Change-$0.00 (-0.00%)
Volume$6.44K
CapitalizationN/A
Lantern Pharma
Price$3.05
Change-$0.09 (-2.87%)
Volume$1.98K
CapitalizationN/A
GLYC vs LTRN Comparison Chart
Loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLYC vs. LTRN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLYC is a Hold and LTRN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (GLYC: $0.23 vs. LTRN: $3.14)
Brand notoriety: GLYC and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLYC: 28% vs. LTRN: 65%
Market capitalization -- GLYC: $15.07M vs. LTRN: $33.76M
GLYC [@Biotechnology] is valued at $15.07M. LTRN’s [@Biotechnology] market capitalization is $33.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLYC’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • GLYC’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than GLYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLYC’s TA Score shows that 4 TA indicator(s) are bullish while LTRN’s TA Score has 3 bullish TA indicator(s).

  • GLYC’s TA Score: 4 bullish, 6 bearish.
  • LTRN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GLYC is a better buy in the short-term than LTRN.

Price Growth

GLYC (@Biotechnology) experienced а -2.05% price change this week, while LTRN (@Biotechnology) price change was -8.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GLYC is expected to report earnings on Feb 27, 2025.

LTRN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN($33.8M) has a higher market cap than GLYC($15.1M). LTRN YTD gains are higher at: -26.519 vs. GLYC (-90.089). LTRN has higher annual earnings (EBITDA): -21.18M vs. GLYC (-36.73M). LTRN has more cash in the bank: 28.1M vs. GLYC (14.4M). GLYC has less debt than LTRN: GLYC (262K) vs LTRN (291K). GLYC has higher revenues than LTRN: GLYC (10K) vs LTRN (0).
GLYCLTRNGLYC / LTRN
Capitalization15.1M33.8M45%
EBITDA-36.73M-21.18M173%
Gain YTD-90.089-26.519340%
P/E RatioN/AN/A-
Revenue10K0-
Total Cash14.4M28.1M51%
Total Debt262K291K90%
FUNDAMENTALS RATINGS
GLYC: Fundamental Ratings
GLYC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLYCLTRN
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUIZ2.930.14
+5.20%
Huize Holding Limited
FIVN42.631.15
+2.77%
Five9
KW10.050.07
+0.70%
Kennedy-Wilson Holdings
LXFR13.180.05
+0.38%
Luxfer Holdings PLC
ARGX623.82-2.21
-0.35%
argenx SE

GLYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLYC has been closely correlated with LYRA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLYC jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLYC
1D Price
Change %
GLYC100%
+13.82%
LYRA - GLYC
75%
Closely correlated
+5.88%
EYPT - GLYC
46%
Loosely correlated
-0.28%
AXON - GLYC
36%
Loosely correlated
+2.60%
IONS - GLYC
35%
Loosely correlated
+0.11%
MDGL - GLYC
34%
Loosely correlated
+5.12%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-2.02%
AXON - LTRN
36%
Loosely correlated
+2.60%
GLYC - LTRN
34%
Loosely correlated
+13.82%
NAUT - LTRN
32%
Poorly correlated
-2.22%
ORMP - LTRN
31%
Poorly correlated
-4.82%
SAGE - LTRN
30%
Poorly correlated
+12.20%
More